Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) issued its earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a return on equity of 0.56% and a net margin of 0.83%. The company had revenue of […]